Attached files
file | filename |
---|---|
EX-10.17 - EXHIBIT 10.17 - Sagimet Biosciences Inc. | tm218447d4_ex10-17.htm |
EX-10.16 - EXHBIT 10.16 - Sagimet Biosciences Inc. | tm218447d4_ex10-16.htm |
EX-10.15 - EXHIBIT 10.15 - Sagimet Biosciences Inc. | tm218447d4_ex10-15.htm |
EX-10.14 - EXHIBIT 10.14 - Sagimet Biosciences Inc. | tm218447d4_ex10-14.htm |
EX-10.10 - EXHIBIT 10.10 - Sagimet Biosciences Inc. | tm218447d4_ex10-10.htm |
EX-10.4 - EXHIBIT 10.4 - Sagimet Biosciences Inc. | tm218447d4_ex10-4.htm |
EX-10.3 - EXHIBIT 10.3 - Sagimet Biosciences Inc. | tm218447d4_ex10-3.htm |
EX-10.2 - EXHIBIT 10.2 - Sagimet Biosciences Inc. | tm218447d4_ex10-2.htm |
EX-10.1 - EXHIBIT 10.1 - Sagimet Biosciences Inc. | tm218447d4_ex10-1.htm |
EX-4.2 - EXHIBIT 4.2 - Sagimet Biosciences Inc. | tm218447d4_ex4-2.htm |
EX-3.3 - EXHIBIT 3.3 - Sagimet Biosciences Inc. | tm218447d4_ex3-3.htm |
EX-3.1 - EXHIBIT 3.1 - Sagimet Biosciences Inc. | tm218447d4_ex3-1.htm |
S-1 - S-1 - Sagimet Biosciences Inc. | tm218447-3_drs.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-1 of our report dated March 10, 2021, relating to the financial statements of Sagimet Biosciences Inc. We also consent to the reference to us under the heading "Experts" in such Registration Statement.
/s/ Deloitte & Touche LLP
San Jose, California
April 16, 2021